You need to enable JavaScript to run this app.
FDA Panel Faces ‘Conundrum’ with Mortality Assessments on Paclitaxel-Coated Devices
Regulatory News
Ana Mulero
Regulatory NewsAna Mulero
Regulatory NewsAna Mulero